Abstract
Objective To investigate the therapeutic effect of ulinastatin in treatment for heavy heart failure patients with coronary heart disease (CHD).Methods Eighty-two patients with heavy heart failure (NYHA ratings Ⅲ ～ Ⅳ class) and CHD were randomly divided into two groups,all patients used diuretic,angiotensin converting enzyme,etc.And test group was given intravenous drip with ulinastatin for 7 days.The CRP,NT-proBNP and the left ventricular ejection fraction (EF) changes were observed.Results After treatment,CRP and NT-proBNP could be reduced,the clinical heart function of the patients in the two groups was improved; the left ventricular EF of patients in the test group was higher than that in the control group.Conclusion Conventional treatment plus ulinastatin could significantly improve the immune condition and reduce the inflammatory reaction in CHF patients. Key words: Ulinastatin; Coronary heart disease (CHD); Chronic heart failure (CHF); pro-BNP; CRP
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
